Actively Recruiting

Age: 2Years +
All Genders
NCT05799118

Study of the Role of Genetic Modifiers in Hemoglobinopathies

Led by Cyprus Institute of Neurology and Genetics · Updated on 2024-03-20

30000

Participants Needed

26

Research Sites

260 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study will investigate the role of genetic modifiers in hemoglobinopathies through a large-scale, multi-ethnic genome-wide association study (GWAS).

CONDITIONS

Official Title

Study of the Role of Genetic Modifiers in Hemoglobinopathies

Who Can Participate

Age: 2Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Clinical diagnosis of an inherited hemoglobinopathy, including sickle cell disease, beta-thalassemia, or alpha-thalassemia; all genotypes accepted
  • Age 2 years or older at the time of phenotypic data collection
  • No restrictions on gender, ethnicity, or other health conditions
Not Eligible

You will not qualify if you...

  • Patients who have received stem cell transplantation or genetic therapy
  • Age under 2 years at the time of phenotypic data collection
  • Participant or legal representative unwilling or unable to provide consent

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 26 locations

1

Boston Children's Hospital

Boston, Massachusetts, United States, 02115

Actively Recruiting

2

Lucrecia Paím Maternity

Luanda, Angola

Actively Recruiting

3

University of Buenos Aires

Buenos Aires, Argentina

Not Yet Recruiting

4

University Hospitals Leuven

Leuven, Belgium

Not Yet Recruiting

5

Universiti Brunei Darussalam

Brunei, Brunei

Not Yet Recruiting

6

Larnaca General Hospital

Larnaca, Cyprus

Actively Recruiting

7

Limassol General Hospital

Limassol, Cyprus

Actively Recruiting

8

Archbishop Makarios III Hospital

Nicosia, Cyprus

Actively Recruiting

9

Paphos General Hospital

Paphos, Cyprus

Actively Recruiting

10

Centre Hospitalier Monkole

Kinshasa, Democratic Republic of the Congo

Actively Recruiting

11

Rigshospitalet

Copenhagen, Denmark

Actively Recruiting

12

Hippokrateio Hospital of Athens

Athens, Greece

Actively Recruiting

13

Laiko General Hospital

Athens, Greece

Actively Recruiting

14

National and Kapodistrian University of Athens

Athens, Greece

Not Yet Recruiting

15

General Hospital of Larissa

Larissa, Greece

Actively Recruiting

16

Emek Medical Centre

Afula, Israel

Not Yet Recruiting

17

University of Turin

Turin, Italy

Not Yet Recruiting

18

Ampang Hospital

Ampang, Malaysia

Actively Recruiting

19

Universiti Kebangsaan Malaysia

Bangi, Malaysia

Actively Recruiting

20

Universiti Sains Malaysia

Kota Bharu, Malaysia

Actively Recruiting

21

University of Abuja

Abuja, Nigeria

Actively Recruiting

22

Kaduna State University

Kaduna, Nigeria

Actively Recruiting

23

Ahmadu Bello University

Zaria, Nigeria

Actively Recruiting

24

University of Lahore

Lahore, Pakistan

Not Yet Recruiting

25

Centro Hospitalar e Universitário de Coimbra

Coimbra, Portugal

Not Yet Recruiting

26

Hospital Clínico San Carlos

Madrid, Spain

Not Yet Recruiting

Loading map...

Research Team

P

Petros Kountouris, PhD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Study of the Role of Genetic Modifiers in Hemoglobinopathies | DecenTrialz